Cargando…

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”

Detalles Bibliográficos
Autores principales: Tsang, Venessa H M, McGrath, Rachel T, Clifton-Bligh, Roderick J, Scolyer, Richard A, Jakrot, Valerie, Guminski, Alexander D, Long, Georgina V, Menzies, Alexander M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170215/
https://www.ncbi.nlm.nih.gov/pubmed/32188993
http://dx.doi.org/10.1210/clinem/dgaa144
_version_ 1783523849572188160
author Tsang, Venessa H M
McGrath, Rachel T
Clifton-Bligh, Roderick J
Scolyer, Richard A
Jakrot, Valerie
Guminski, Alexander D
Long, Georgina V
Menzies, Alexander M
author_facet Tsang, Venessa H M
McGrath, Rachel T
Clifton-Bligh, Roderick J
Scolyer, Richard A
Jakrot, Valerie
Guminski, Alexander D
Long, Georgina V
Menzies, Alexander M
author_sort Tsang, Venessa H M
collection PubMed
description
format Online
Article
Text
id pubmed-7170215
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71702152020-04-24 Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” Tsang, Venessa H M McGrath, Rachel T Clifton-Bligh, Roderick J Scolyer, Richard A Jakrot, Valerie Guminski, Alexander D Long, Georgina V Menzies, Alexander M J Clin Endocrinol Metab Online Only Articles Oxford University Press 2020-03-19 /pmc/articles/PMC7170215/ /pubmed/32188993 http://dx.doi.org/10.1210/clinem/dgaa144 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Online Only Articles
Tsang, Venessa H M
McGrath, Rachel T
Clifton-Bligh, Roderick J
Scolyer, Richard A
Jakrot, Valerie
Guminski, Alexander D
Long, Georgina V
Menzies, Alexander M
Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
title Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
title_full Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
title_fullStr Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
title_full_unstemmed Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
title_short Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
title_sort response to letter to the editor: “checkpoint inhibitor-associated autoimmune diabetes is distinct from type 1 diabetes”
topic Online Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170215/
https://www.ncbi.nlm.nih.gov/pubmed/32188993
http://dx.doi.org/10.1210/clinem/dgaa144
work_keys_str_mv AT tsangvenessahm responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT mcgrathrachelt responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT cliftonblighroderickj responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT scolyerricharda responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT jakrotvalerie responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT guminskialexanderd responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT longgeorginav responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes
AT menziesalexanderm responsetolettertotheeditorcheckpointinhibitorassociatedautoimmunediabetesisdistinctfromtype1diabetes